|
1
|
Cazzagon N, Trevisani F, Maddalo G, et al:
Italian Liver Cancer (ITA.LI.CA) Group: Rise and fall of
HCV-related hepatocellular carcinoma in Italy: A long-term survey
from the ITA.LI.CA centres. Liver Int. 33:1420–1427. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fares N and Peron JM: Epidemiology,
natural history, and risk factors of hepatocellular carcinoma. Rev
Prat. 63:216–217, 220–212. 2013.(In French). PubMed/NCBI
|
|
3
|
Matsuda Y and Ichida T: Impact of
hepatitis B virus X protein on the DNA damage response during
hepatocarcinogenesis. Med Mol Morphol. 42:138–142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rawat S, Clippinger AJ and Bouchard MJ:
Modulation of apoptotic signaling by the hepatitis B virus X
protein. Viruses. 4:2945–2972. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bouchard MJ and Navas-Martin S: Hepatitis
B and C virus hepatocarcinogenesis: Lessons learned and future
challenges. Cancer Lett. 305:123–143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim JK, Chang HY, Lee JM, Baatarkhuu O,
Yoon YJ, Park JY, Kim Y, Han KH, Chon CY and Ahn SH: Specific
mutations in the enhancer II/core promoter/precore regions of
hepatitis B virus subgenotype C2 in Korean patients with
hepatocellular carcinoma. J Med Virol. 81:1002–1008. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu L, Li Y, Zhang S, Yu D and Zhu M:
Hepatitis B virus X protein mutant upregulates CENP-A expression in
hepatoma cells. Oncol Rep. 27:168–173. 2012.PubMed/NCBI
|
|
8
|
Tu H, Bonura C, Giannini C, Mouly H,
Soussan P, Kew M, Paterlini-Bréchot P, Bréchot C and Kremsdorf D:
Biological impact of natural COOH-terminal deletions of hepatitis B
virus X protein in hepatocellular carcinoma tissues. Cancer Res.
61:7803–7810. 2001.PubMed/NCBI
|
|
9
|
Yeh CT, Shen CH, Tai DI, Chu CM and Liaw
YF: Identification and characterization of a prevalent hepatitis B
virus X protein mutant in Taiwanese patients with hepatocellular
carcinoma. Oncogene. 19:5213–5220. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaneko M, Uchida T, Moriyama M, Arakawa Y,
Shikata T, Gotoh K and Mima S: Probable implication of mutations of
the X open reading frame in the onset of fulminant hepatitis B. J
Med Virol. 47:204–208. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi W, Wang Q, Zhao X and Zhao L: Study on
the relationship between the mutations of hepatitis B virus X gene
and precore gene, related factors and hepatocellular carcinoma.
Chinas Med. 8:1673–4777. 2013.(In Chinese).
|
|
12
|
Uchida T, Saitoh T and Shinzawa H:
Mutations of the X region of hepatitis B virus and their clinical
implications. Pathol Int. 47:183–193. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shinkai N, Tanaka Y, Ito K, Mukaide M,
Hasegawa I, Asahina Y, Izumi N, Yatsuhashi H, Orito E, Joh T, et
al: Influence of hepatitis B virus X and core promoter mutations on
hepatocellular carcinoma among patients infected with subgenotype
C2. J Clin Microbiol. 45:3191–3197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cabibbo G, Antonucci M and Genco C: Update
on new approaches in the management of hepatocellular carcinoma.
Hepat Med. 2:163–173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu S, Zhang H, Gu C, Yin J, He Y, Xie J
and Cao G: Associations between hepatitis B virus mutations and the
risk of hepatocellular carcinoma: A meta-analysis. J Natl Cancer
Inst. 101:1066–1082. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takahashi K, Ohta Y, Kanai K, Akahane Y,
Iwasa Y, Hino K, Ohno N, Yoshizawa H and Mishiro S: Clinical
implications of mutations C-to-T1653 and T-to-C/A/G1753 of
hepatitis B virus genotype C genome in chronic liver disease. Arch
Virol. 144:1299–1308. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tanaka Y, Mukaide M, Orito E, Yuen MF, Ito
K, Kurbanov F, Sugauchi F, Asahina Y, Izumi N, Kato M, et al:
Specific mutations in enhancer II/core promoter of hepatitis B
virus subgenotypes C1/C2 increase the risk of hepatocellular
carcinoma. J Hepatol. 45:646–653. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Tanaka Y, Huang Y, Kurbanov F,
Chen J, Zeng G, Zhou B, Mizokami M and Hou J: Clinical and
virological characteristics of hepatitis B virus subgenotypes Ba,
C1 and C2 in China. J Clin Microbiol. 45:1491–1496. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim HJ, Park JH, Jee Y, Lee SA, Kim H,
Song BC, Yang S, Lee M, Yoon JH, Kim YJ, et al: Hepatitis B virus X
mutations occurring naturally associated with clinical severity of
liver disease among Korean patients with chronic genotype C
infection. J Med Virol. 80:1337–1343. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Choi CS, Cho EY, Park R, Kim SJ, Cho JH
and Kim HC: X gene mutations in hepatitis B patients with
cirrhosis, with and without hepatocellular carcinoma. J Med Virol.
81:1721–1725. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tangkijvanich P, Sa-Nguanmoo P, Mahachai
V, Theamboonlers A and Poovorawan Y: A case-control study on
sequence variations in the enhancer II/core promoter/precore and X
genes of hepatitis B virus in patients with hepatocellular
carcinoma. Hepatol Int. 4:577–584. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li W, Chen G, Yu X, Shi Y, Peng M and Wei
J: Accumulation of the mutations in basal core promoter of
hepatitis B virus subgenotype C1 increase the risk of
hepatocellular carcinoma in Southern China. Int J Clin Exp Pathol.
6:1076–1085. 2013.PubMed/NCBI
|
|
23
|
Lyu H, Lee D, Chung YH, Kim JA, Lee JH,
Jin YJ, Park W, Mathews P, Jaffee E, Zheng L, et al: Synergistic
effects of A1896, T1653 and T1762/A1764 mutations in genotype c2
hepatitis B virus on development of hepatocellular carcinoma. J
Viral Hepat. 20:219–224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang X and Hollinger FB: Occult hepatitis
B virus infection and hepatocellular carcinoma: A systematic
review. J Viral Hepat. 21:153–162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin CL, Chen JD, Liu CJ, Lee PH, Chen PJ,
Lai MY, Kao JH and Chen DS: Clinicopathological differences between
hepatitis B viral genotype B- and C-related resectable
hepatocellular carcinoma. J Viral Hepat. 14:64–69. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kay A and Zoulim F: Hepatitis B virus
genetic variability and evolution. Virus Res. 127:164–176. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yim HJ and Lok AS: Natural history of
chronic hepatitis B virus infection: What we knew in 1981 and what
we know in 2005. Hepatology. 43(Suppl 1): S173–S181. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jammeh S, Tavner F, Watson R, Thomas HC
and Karayiannis P: Effect of basal core promoter and pre-core
mutations on hepatitis B virus replication. J Gen Virol.
89:901–909. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Buckwold VE, Xu Z, Chen M, Yen TS and Ou
JH: Effects of a naturally occurring mutation in the hepatitis B
virus basal core promoter on precore gene expression and viral
replication. J Virol. 70:5845–5851. 1996.PubMed/NCBI
|
|
30
|
Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y,
Zhang P, Xu L, Tan X, Chen J, et al: Role of hepatitis B virus
genotype mixture, subgenotypes C2 and B2 on hepatocellular
carcinoma: Compared with chronic hepatitis B and asymptomatic
carrier state in the same area. Carcinogenesis. 29:1685–1691. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen
CL, Su J, Wang LY, Lu SN, You SL, Chen DS, et al: REVEAL-HBV Study
Group: Associations between hepatitis B virus genotype and mutants
and the risk of hepatocellular carcinoma. J Natl Cancer Inst.
100:1134–1143. 2008. View Article : Google Scholar : PubMed/NCBI
|
